Cargando…
Angiotensin converting enzyme polymorphism and ischemic stroke
OBJECTIVES: To assess the polymorphism of angiotensin converting enzyme (ACE) in ischemic stroke in an Egyptian sample. METHODS: One hundred subjects (70 ischemic stroke patients, and 30 healthy controls) were included in case control cross sectional study during the period from January 2017 to Janu...
Autores principales: | Salem, Gelan M., Gab-Allah, Ghada K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Riyadh : Armed Forces Hospital
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015476/ https://www.ncbi.nlm.nih.gov/pubmed/32683396 http://dx.doi.org/10.17712/nsj.2020.3.20190117 |
Ejemplares similares
-
Angiotensin I - Converting Enzyme Gene Polymorphism and Activity in Patients with Ischemic Stroke
por: Stankovic, Sanja, et al.
Publicado: (2011) -
Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017) -
Serum activity of angiotensin converting enzyme 2 is decreased in patients with acute ischemic stroke
por: Bennion, Douglas M, et al.
Publicado: (2016) -
Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014) -
Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?
por: Brooks, John M., et al.
Publicado: (2018)